Details of the Drug

General Information of Drug (ID: DMHDI8H)

• Drug Name: YPL-001

Indication

Disease Entry	ICD 11	Status	REF
Chronic obstructive pulmonary disease	CA22	Phase 2	[1]

• Cross-matching ID: TTD ID: DGT7B6

References

• [1] ClinicalTrials.gov (NCT02272634) A Randomized, Double-Blind, Placebo Controlled, Multicenter 2a Study to Assess Safety, Daily Respiratory Symptoms, PK, and Biomarker Variations After Administration of Either YPL-001, or Placebo in Patients With Moderate-to-Severe COPD. U.S.National Institutes of Health.